Nuvectra™ Appoints Neuromodulation Veteran Ben Tranchina as Chief Technology Officer
August 02, 2018 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today the appointment of Ben Tranchina as Chief Technology...
Nuvectra™ to Report Second Quarter 2018 Financial Results on August 7, 2018
July 31, 2018 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, July 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the...
Nuvectra Completes 2,000 U.S. Algovita® SCS System Implantations
July 10, 2018 08:01 ET
|
Nuvectra Corporation
PLANO, Texas, July 10, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that the Company’s Algovita® Spinal Cord Stimulation...
Nuvectra Provides Update on FDA and TÜV SÜD Review of Virtis™ PMA and CE Mark Applications
July 02, 2018 07:30 ET
|
Nuvectra Corporation
PLANO, Texas, July 02, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today provided an update on its U.S. Food and Drug Administration (FDA)...
Nuvectra Added to the Russell 2000® Index
June 25, 2018 08:01 ET
|
Nuvectra Corporation
PLANO, Texas, June 25, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it was added to the Russell 2000® Index when...
Nuvectra to Present at Two Upcoming Investor Conferences
May 17, 2018 08:30 ET
|
Nuvectra Corporation
PLANO, Texas, May 17, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter...
Nuvectra™ Reports First Quarter 2018 Financial Results
May 02, 2018 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, May 02, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended...
Nuvectra™ to Report First Quarter 2018 Financial Results on May 2, 2018
April 23, 2018 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, April 23, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the...
Nuvectra™ Reports Fourth Quarter and Full Year 2017 Financial Results
March 06, 2018 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, March 06, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, today announced financial results for the fourth quarter and full year...
Nuvectra to Present at Two Upcoming Investor Conferences
February 27, 2018 08:30 ET
|
Nuvectra Corporation
PLANO, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter...